While we are in the middle of the endgame strategy to end polio, wild polio virus cases are still occurring in the border area between Afghanistan and Pakistan. We pass along weekly updates from the Global Polio Eradication Initiative on this site, click Read more... below.

Polio this week as of 10 July 2018

 
 
 
HeadlinesTA Disease Outbreak News (DON) notification was issued on 10 July on the Democratic Republic of the Congo’s three concurrent circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreaks.
   Papua New Guinea prepares for the launch of large-scale immunization campaigns in Morobe, Madang and Eastern Highlands provinces, set to commence next week.
   Summary of new cases this week: Last week’s advance notifications of one wild poliovirus type 1 (WPV1) case in Afghanistan and one cVDPV2 case in Somalia with a cVDPV2 positive community contact have been confirmed. Two new WPV1 positive environmental samples have been reported in Afghanistan, and four new WPV1 positive environmental samples have been reported in Pakistan. See country sections below for more details.
   A new GPEI ‘Coffee With Polio Experts’ video interview featuring World Health Organization’s Honorine Mollard Billard looks at the importance of country support to vaccination campaigns, why polio-free countries need to maintain high immunity levels, and additional health interventions offered to communities during polio campaigns.
 
Afghanistan:   Last week’s advance notification of one wild poliovirus type 1 (WPV1) case in Nad-e-Ali districtHelmand province, has been confirmed. The case had onset of paralysis on 1 June. This brings the total number of WPV1 cases in 2018 (in Afghanistan) to nine.
   A sub-national immunization days campaign aiming to reach 6.4 million children under five years of age in 225 high risk districts of 27 provinces, primarily in the southern and eastern parts of the country including Kabul city, has concluded.
   Two new WPV1 positive environmental samples have been reported: one in Kandahar City, Kandahar province, and one in Jalalabad, Nangarhar province.
   Read the latest polio update from Afghanistan to see information on cases, surveillance and vaccination campaigns.

Pakistan:  No new cases of wild poliovirus type 1 (WPV1) were reported this week.
   The total number of officially reported WPV1 cases in Pakistan in 2018 is three.
   The latest case had onset of paralysis on 18 May, from Dukki district, Balochistan province.
   Four new WPV1 positive environmental samples have been reported this week: one in Peshawar and one in Kohat, Khyber Pakhtunkhwa province (both 26 June), one in Karachi, Sindh province (23 June), and one in Islamabad, Punjab province (24 June).
   A door-to-door polio vaccination round to reach approximately 11 million children in high-risk districts of Pakistan has concluded.
Read the latest polio update from Pakistan to see information on cases, surveillance and vaccination campaigns.

 Nigeria:   No new cases of wild poliovirus type 1 (WPV1) were reported in the past week.
   Four WPV1 cases were reported in Nigeria in 2016 and no cases have been reported in 2017 or 2018. The most recent WPV1 case (by date of onset) was reported in Monguno Local Government Area, Borno State, with onset on 21 August 2016.
   One new circulating vaccine-derived poliovirus type 2 (cVDPV2) positive environmental sample has been reported in Jigawa state, collected on 2 May.
   Since confirmation of cVDPV2 in Nigeria, virus has been isolated from environmental samples and one case with onset of paralysis on 15 April.
   In response to cVDPV2 detection, the country has conducted additional acute flaccid paralysis surveillance strengthening activities including enhanced active surveillance visits, and community sampling. The program has also carried out an extensive search for type 2 containing vaccines (tOPV/mOPV2) in the areas surrounding where the virus was detected.
   The GPEI is working with regional and country counterparts and partners to support an outbreak response.
   Read our Nigeria country page to see information on surveillance and vaccination campaigns.